Hyperosmolar Hyperglycemic State (HHS)
The most likely cause of this patient's symptoms is hyperosmolar hyperglycemic state (HHS), not arginine vasopressin resistance, central diabetes insipidus, hypovolemic hyponatremia, or primary polydipsia.
Clinical Reasoning
This patient presents with the classic triad defining HHS: severe hyperglycemia (>1000 mg/dL), profound hypernatremia (169 mEq/L), and markedly elevated serum osmolality (443 mOsm/kg) 1, 2. The diagnostic criteria for HHS are clearly met: plasma glucose ≥600 mg/dL, arterial pH >7.30, bicarbonate >15 mEq/l, and effective serum osmolality >320 mOsm/kg 2.
Why This is HHS and Not the Other Options:
Concentrated urine (721 mOsm/kg) is the key distinguishing feature. This concentrated urine indicates that arginine vasopressin (AVP) is being produced and the kidneys are responding appropriately to it. This single finding eliminates three of the differential diagnoses:
Not AVP resistance (nephrogenic DI): In AVP resistance, the kidneys cannot respond to vasopressin, resulting in dilute urine with osmolality <300 mOsm/kg despite hypernatremia 3, 4. This patient's concentrated urine (721 mOsm/kg) proves the kidneys are responding normally to AVP.
Not central diabetes insipidus: Central DI causes dilute urine due to inadequate AVP production. Patients with central DI typically have urine osmolality <300 mOsm/kg and cannot concentrate urine appropriately 5, 6, 7, 8. This patient's highly concentrated urine excludes this diagnosis.
Not primary polydipsia: Primary polydipsia causes hyponatremia (not hypernatremia) due to excessive water intake diluting serum sodium. This patient has severe hypernatremia, the opposite finding.
Not hypovolemic hyponatremia: The patient has hypernatremia (sodium 169 mEq/L), not hyponatremia. This option is physiologically incompatible with the presentation.
Pathophysiology in This Case
The hypernatremia in HHS results from osmotic diuresis driven by severe hyperglycemia, causing disproportionate free water loss compared to sodium loss 2. The patient's kidneys are appropriately concentrating urine (721 mOsm/kg) in response to dehydration and hypernatremia, demonstrating intact AVP production and renal response. The 19-liter free water deficit reflects massive fluid losses from prolonged osmotic diuresis 2.
The elevated HbA1c of 14% indicates this is likely new-onset type 2 diabetes or severely uncontrolled pre-existing diabetes that progressed to HHS 9, 10. The patient's 6-year absence from medical care supports undiagnosed or untreated diabetes.
Critical Management Points
The serum osmolality reduction must not exceed 3 mOsm/kg/h to prevent cerebral edema 2. With an initial osmolality of 443 mOsm/kg, overly aggressive correction poses significant risk of neurological complications including cerebral edema, which carries 70% mortality 2.
Fluid resuscitation should begin with isotonic saline (0.9% NaCl) at 15-20 ml/kg/h initially, then transition to 0.45% NaCl at 4-14 ml/kg/h once hemodynamic stability is achieved 2. The corrected serum sodium (accounting for hyperglycemia) guides fluid choice: use 0.45% NaCl if corrected sodium is normal or elevated, 0.9% NaCl if corrected sodium is low 2.
Insulin infusion at 0.1 units/kg/h should be started only after excluding hypokalemia (K+ <3.3 mEq/L) 2, 11. Once glucose reaches 250-300 mg/dL, add dextrose to IV fluids and maintain glucose at this level until hyperosmolarity and mental status improve 2.
Potassium replacement (20-30 mEq/L in IV fluids, 2/3 KCl and 1/3 KPO4) is essential once renal function is confirmed and potassium is known, as insulin therapy will drive potassium intracellularly 2.
Common Pitfalls to Avoid
Do not confuse the polyuria and polydipsia in HHS with diabetes insipidus. The concentrated urine in HHS (as in this case) distinguishes it from DI, where urine remains inappropriately dilute 3, 5, 6.
Avoid overly rapid correction of hypernatremia and hyperosmolality, which can precipitate fatal cerebral edema 2. Monitor serum osmolality frequently and adjust fluid rates accordingly.
Do not discontinue IV insulin before administering subcutaneous basal insulin 2-4 hours prior, as this prevents rebound hyperglycemia and potential progression to DKA 1, 11.